- Published at
- by seekingalpha.com
negative
negative
enVVeno Medical (NVNO) Stock: Unique Exposure To Venous Treatment Domain
enVVeno Medical continues to advance its key product pipeline through two clinical trials. The two latest clinical trials have garnered investor's attention. Read here for the stock outlook.